Discover
MRNA
Moderna, Inc.
225.00
1 x 210.52
2 x 230.00
bid
ask
+
28.00
14.21%
2 @ 07:59 PM
225.47 +0.47 (0.21%)
| Ytd | 662.97% | |
| 1y | 717.29% |
197.17
day range
225.00
22.36
52 week range
225.00
| Open | 199.10 | Prev Close | 197.00 | Low | 197.17 | High | 225.00 | Mkt Cap | 89.83B |
| Vol | 28.95M | Avg Vol | 17.95M | EPS | -9.11 | P/E | N/A | Forward P/E | -50.70 |
| Beta | 1.09 | Short Ratio | 0.99 | Inst. Own | 80.46% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 134.92 | 200-d Avg | 71.68 | 1yr Est | 122.67 |
| Income Statement | |||
| Total Revenue | 145.00M | ||
| Revenues (USD) | 145.00M | ||
| Cost of Revenue | 93.00M | ||
| Gross Profit | 52.00M | ||
| Operating Expenses | 867.00M | ||
| Research and Development Expense | 651.00M | ||
| Selling, General and Administrative Expense | 216.00M | ||
| Operating Income | -815.00M | ||
| Income Tax Expense | 15.00M | ||
| Net Income | -782.00M | ||
| Net Income Common Stock | -782.00M | ||
| Net Income Common Stock (USD) | -782.00M | ||
| Consolidated Income | -782.00M | ||
| Earnings per Basic Share | -1.97 | ||
| Earnings per Basic Share (USD) | -1.97 | ||
| Earnings per Diluted Share | -1.97 | ||
| Earning Before Interest & Taxes (EBIT) | -767.00M | ||
| Earning Before Interest & Taxes (USD) | -767.00M | ||
| Weighted Average Shares | 398.00M | ||
| Weighted Average Shares Diluted | 398.00M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.72B | ||
| Cash and Equivalents (USD) | 1.72B | ||
| Investments | 5.19B | ||
| Investments Current | 3.42B | ||
| Investments Non-Current | 1.77B | ||
| Trade and Non-Trade Receivables | 17.00M | ||
| Current Assets | 5.82B | ||
| Property, Plant & Equipment Net | 2.76B | ||
| Total Assets | 10.96B | ||
| Total Debt | 1.24B | ||
| Current Liabilities | 2.53B | ||
| Debt Non-Current | 1.24B | ||
| Total Liabilities | 4.20B | ||
| Accumulated Retained Earnings (Deficit) | 5.10B | ||
| Accumulated Other Comprehensive Income | 19.00M | ||
| Shareholders Equity | 6.76B | ||
| Shareholders Equity (USD) | 6.76B | ||
| Assets Non-Current | 5.15B | ||
| Total Debt (USD) | 1.24B | ||
| Deferred Revenue | 442.00M | ||
| Inventory | 280.00M | ||
| Liabilities Non-Current | 1.67B | ||
| Trade and Non-Trade Payables | 167.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 63.00M | ||
| Net Cash Flow from Financing | 14.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -185.00M | ||
| Capital Expenditure | -37.00M | ||
| Issuance (Purchase) of Equity Shares | 23.00M | ||
| Issuance (Repayment) of Debt Securities | -7.00M | ||
| Net Cash Flow from Investing | 329.00M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 366.00M | ||
| Net Cash Flow from Operations | -526.00M | ||
| Effect of Exchange Rate Changes on Cash | -2.00M | ||
| Share Based Compensation | 120.00M | ||